Hard Shell Home Use Portable 1.3 ATA Oxygen Hyperbaric Chamber

Name: Hard Shell Home Use Portable 1.3 ATA Oxygen Hyperbaric Chamber
Brand: Hebei Lixin Medical Engineering Co., Ltd
SKU: 1964721241

Hebei, ChinaHebei Lixin Medical Engineering Co., Ltd

US$3,010.00-4,332.00

1 Set

Product profile

Customization

Available

Type

Health Oxygen Therapy

Function

Micro Hyperbaric Oxygen Chamber

Model NO.

Hyperbaric Oxygen Chamber

Theory

Health Oxygen Therapy

Certification

Group

Students, Seniors, Fitness Enthusiasts, Beauty Ent

Oxygen Concentration in The Chamber

21%-23%

Cabin Working Pressure

10-30kpa(Adjustable)

Noise

60dB

Working Temperature Inside The Cabin

with Ambient Temperature+3 ℃

Transport Package

Wooden Frame

Specification

Customizable

Trademark

Baooxygen Four Seasons

Origin

Hebeihengshui

Production Capacity

500 Sets/Year

Company profile

Importers and ExportersSelf-brandedPatents AwardedManagement Certification

Hebei Lixin Medical Engineering Co., Ltd

Hebei, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 3 Years CertifiedNearest Port: Tianjin PortAverage Response Time: ≤0.65h

AI-Powered supplier vetting

SummaryHebei Lixin Medical Engineering Co., Ltd is a China-based factory established in 2011 with 45 employees. It supplies medical oxygen generators, central oxygen supply systems, purification engineering, and related medical infrastructure solutions. The company reports 24 national patents and software copyrights, 17 system certifications including ISO 9001 and ISO 13485, nationwide sales and service coverage through seven regional hubs and 30 urban service centers, and experience serving hundreds of medical institutions. It also states that 41%–50% of total sales come from exports and that exporting began in 2024. However, the provided information does not confirm outsourcing procedures, valid manufacturing-capacity contracts, inventory services, OEM/ODM or SDK capabilities, raw-material traceability, or financial strength. Audit information identifies TÜV Rheinland and an audit period from 2024-03-07 to 2025-03-06, but the audit result code is not explained.

Supplier typeThe supplier is identified as a factory and a limited company located in Jizhou District, Hengshui, Hebei, China. It was established in 2011 and has 45 employees, indicating a directly operating manufacturing entity rather than only a trading company.

CertificationsThe company states that it holds 17 system certifications, including ISO 9001, ISO 13485, GB/T 50430, OHSAS 28001, ISO 45001, and a five-star after-sales service certification. TÜV Rheinland is identified as the audit organization, although the meaning of the recorded audit result code is not provided.

After-Sales capabilityThe supplier reports seven regional hubs and service centers in 30 urban areas across China, alongside a five-star after-sales service certification. This directly supports established domestic service coverage and after-sales capability.

R&D capabilityThe company describes robust core technology and personalized integration capabilities, and reports 24 national patents and software copyrights. These stated intellectual-property holdings provide explicit evidence of innovation activity, although specific R&D staffing, product-development timelines, SDK availability, and ODM capability remain unconfirmed.

Production capacityThe supplier is classified as a factory and offers medical oxygen generators, central oxygen supply systems, and purification engineering. Its stated delivery of services to hundreds of medical institutions supports implementation experience, but the slices do not quantify production capacity, factory equipment, throughput, or inventory capability.

Customization capabilityThe company explicitly states that it provides comprehensive, tailor-made medical oxygen system solutions and has personalized integration capabilities. This supports customization and system-integration competence for medical oxygen projects, while specific customization methods or limits are not detailed.

Client casesThe supplier reports delivering medical center oxygen-production services to hundreds of medical institutions and receiving broad recognition for reliability and expertise. This is direct evidence of substantial customer-project experience, although individual customer names, project locations, and performance metrics are not provided.